Laurie Kelley

Save One Life: Cheers for 20 Years!

No matter how many dozens of presentations I’ve given over 32 years, being on a TV set, with only cameras to look at, makes me nervous! I wasn’t alone last Thursday evening; Chris Bombardier confided he felt the same way—and this is the guy who did the Seven Summits, including of course Everest! I told him I had no problem once being asked to speak in front of 100 Japanese hematologists in Hiroshima; live audiences are great. But teleprompters?

Michael DeGrandpre, Chris Bombardier, Laurie Kelley

No matter. We went live Thursday evening to celebrate 20 years of bringing funding, service and hope to over 2,000 families with bleeding disorders in developing countries. Two things made the evening unfurl without a hitch: the fantastic team we have in the Save One Life office, especially the untiring efforts of Jodi Weeks and Karen Serevitch, and having the irrepressible Michael DeGrandpre as emcee!

See the entire show here.

The evening was a hit. We met at Charles River Media Group near Channel 5 headquarters in Needham Heights, Massachusetts. Seeing the behind the scenes working of putting on a live show was fascinating.

I had not seen the behind-the-scenes videos that were show throughout the evening: our program partners, sponsors, donors, board members, and even some of the beneficiaries that I had known as children… all grown up and sharing their successes thanks to Save One Life.

I had tried contacting one person, Lisa O’Connor, who originally had given me the idea of Save One Life back in 1997! I still had the yellow lined paper with her idea on it that she had sent me. I had saved it all these years. I just wanted her to watch, so she would know we were crediting her. She never replied. How shocked I was when I saw suddenly a video of her, thanking us all! I was floored, and grateful.

Laurie Kelley with cake!

And I wanted to surprise my mother, by thanking her for the gifts she has given to me when a child: raising us to love children, showing how to help one another, and above all, raising me in a faith that puts charitable giving to the poor and suffering above all things. Again, the team surprised me totally, when, after my thanks to her, she was in a video, offering cheers to us!

Watch the event here!

We covered our programs, and the videos highlighted the impact these have made on those who participated: young men who have become doctors or engineers through our scholarship program; families that benefitted from our micro-enterprise grant program; children who participated in camp; and of course, over 78 countries getting factor from Project SHARE.

The event was also a fundraiser. Thanks to Michael’s infomercial skill set, we raised over $36,000 with an additional surprise: a $100,000 gift from on donor, the Muir family of California (formerly from Massachusetts, who I had known when our sons with hemophilia were born).

It was truly time to celebrate. After the show, and we said our thank yous and good-byes on air, we retired to the prep room, where champagne and cake awaited! We were elated and happy the program went off without a hitch.

Me: I never would have organized such a thing. It just isn’t me. But I see how a celebration like this allows everyone to share in the joy we have brought to others, and to allows us to celebrate each other as a community. It pumps us up to do more, serve more, and be more.

To Jodi and Karen, to Michael, to the Muirs, to the two donors who provided matches (Eric and Rich) to all our sponsors and donors and program partners: a huge thank you! We could not exist without you. We could not provide the needed help overseas without you.

Cheers to you all! And to 20 more years!

Riding to Remember

Today we hosted a 36-mile ride through scenic and historic Newburyport, Massachusetts, out to Plum Island and back, to honor the memory of the beloved Barry Haarde, and to raise money for the children and young people we serve through Save One Life. Barry started this biking craze in hemophilia, as he rode across the United States six different times, and raised about $250,000 for our nonprofit. When he passed away, we thought to keep his dream alive: to raise awareness of the need of those with bleeding disorders in developing countries, to raise funds to keep our program alive to help them, and to bring our community together.

It threatened rain, and did rain early in the morning, but by the time the riders showed up around 9 am, the sun was struggling through. It was a small group, only six riders, but dedicated! I could not join them this time as I have been dealing with chronic back issues for months, and while on the rebound after medical procedures, didn’t want to risk a flare up. I stayed behind with our team from Save One Life. Fueled by donuts and coffee, the riders took off!

When they returned two plus hours later, we learned that one dropped out due to a health concern, and one—my brother—stopped the ride to assist a painted turtle across the road. Hey, it’s Save One Life, and he did!

Thanks to all who participated, to remember Barry, and to remember our community members overseas in need.

When Insurance Help Doesn’t Help

Miriam Goldstein

Director for Policy, Hemophilia Federation of America

Ed.: Your factor manufacturer probably has an insurance assistance program, to help with expensive copays. What could go wrong? From your insurance company: Checkmate.

Drug manufacturer copay assistance programs help many in the bleeding disorder community. People who live with bleeding disorders rely on medications—clotting factor or other treatments—to control bleeding and preserve their health. These drugs are essential, but expensive, and are needed on an ongoing basis. As a result, many people with bleeding disorders face the prospect of hitting their health insurance out-of-pocket maximums each year, and can reach that limit all at once with one order of factor. Yearly out-of-pocket maximums include copays, coinsurance, and deductibles, with amounts varying from plan to plan. While the Affordable Care Act (ACA) places an annual cap on cost-sharing amounts, that ceiling, depending on plan type, is high—in 2020, between $6,900 and $8,150 for an individual, or between $13,800 and $16,300 for a family. And the prospect of hitting it every year is daunting, to say the least.

Manufacturer copay assistance programs protect patients from this financial burden, and sustain their access to essential medications, by covering patients’ drug-related copay, coinsurance, and deductible expenses. Many programs will cover $12,000 and up in cost-sharing expenses per year. Eligible patients typically must have third-party commercial insurance to participate in these programs.

Unfortunately, in recent years a growing number of health insurers and pharmacy benefit managers (PBMs) have begun claiming that copay assistance programs incentivize patients to demand pricey brand name drugs instead of using more cost-effective generics. Citing the need to counter these incentives and contain costs, some health plans have been taking steps to limit the value of manufacturer copay assistance to patients—while maximizing the amount that the health plans themselves collect from those programs—through the use of “accumulator adjusters.”

What are accumulator adjusters?

Accumulator adjuster programs are used by health insurance plans to limit the value of manufacturer copay assistance programs. When an accumulator is in place, the health plan accepts the manufacturer copay assistance—which is supposed to pay for the patient’s out-of-pocket drug costs—but then doesn’t credit that amount toward the patient’s deductible or out-of-pocket maximum. The health plan draws down the full value of the copay assistance as prescriptions are filled; but then it “adjusts” or resets what is credited to the patient’s cost-sharing obligations back to zero. As a result, a person with a bleeding disorder will still have to personally pay deductibles, copays, and other out-of-pocket expenses, up to the yearly out-of-pocket maximum. At the same time, the health plan appropriates the full amount of the copay assistance—assistance that was supposed to help the patient!

Accumulators leave bleeding disorder patients in a tough financial bind. If this happens to you, please check out the options listed in Hemophilia Federation of America’s (HFA) online Resource Library.1 You may be able to get financial help with your copays from a third-party, charitable nonprofit patient assistance fund.2 Health plans sometimes will not apply accumulators to copay assistance provided by charitable organizations, and will still credit the charitable assistance to patient deductibles and out-of-pocket maximums.

HFA is working with other patient advocacy groups to educate health plans and PBMs about the dangers of accumulators. We urged federal regulators to ban the use of accumulators, where patients don’t have the option to choose a generic drug (as is the case with bleeding disorder patients). Unfortunately, the US Department of Health and Human Services (HHS) rejected this request. In May 2020, HHS finalized a rule3 that allows health insurers to continue using accumulator adjusters for the coming plan year.

HFA and allied groups will continue to advocate for federal and state policies that prioritize patient access to their prescription medications. In the meantime, we need to hear from you! If you learn that your copay assistance will no longer be credited toward your deductible or out-of-pocket maximum, please share your story with HFA’s Project CALLS.4

Collecting data on the impact of accumulators allows us to make a case for change when we ask lawmakers to take action to protect patients from these harmful health plan tactics.

(Originally published in PEN’s Insurance Pulse, 2020)

Miriam Goldstein is director for policy at Hemophilia Federation of America, where her work includes monitoring and analyzing federal legislation and regulations impacting patient access to care; insurance, Medicaid, and Medicare issues; and blood and product safety. Miriam lives in Arlington, Virginia, and is the mother of two adult sons with hemophilia.

1. hemophiliafed.org/resource-library/additional-resources/navigating-patient-assistance-programs 2. Patient assistance funds that offer financial assistance to eligible bleeding disorder patients include the Assistance Fund, Patient Access Network (PAN) Foundation, and Patient Services, Inc. (PSI). 3. US Dep’t of Health and Human Services, Notice of Benefit and Payment Parameters for 2021, 85 Fed. Reg. 29164 (May 14, 2020). 4. projectcalls.org

State of Denial

When you submit an insurance form for coverage, have you ever been denied?   What should you do if you’ve already received a denial of service or medication?

Here are examples of denials that may happen:  

• Your health insurance company won’t let you be seen at a hemophilia treatment center (HTC) for comprehensive care because the HTC isn’t “in-network.”

• You can’t go to an HTC because you’re in a health maintenance organization (HMO). Your managed care company doesn’t have any physical therapists in-network experienced with bleeding disorders.

• Your HTC doctor prescribed a brand of factor replacement therapy, and your insurance company won’t approve it.

What can you do about these denials?

Typically, people tell me they’ve just accepted the insurance company’s decision and denial. But you need to be proactive. Did you or your healthcare provider ask the insurance company to reconsider? Did you file a complaint? You have a right to challenge the decision. You’ll likely get help from your provider, and you may enlist the help of your local hemophilia organization. Consider asking for an appeal even if you have Medicaid. Sometimes, people with Medicaid feel they are getting “free” healthcare and don’t want to rock the boat. No matter what type of healthcare coverage you have, you have the right to ask the company to reconsider.

Is this “appealing”?

Here are some ideas on getting what you need, if you need to appeal:

• Insurance companies are in the business of providing care that leads to good medical outcomes for their members. If you and your healthcare providers can show why something is medically necessary, your chances of getting the insurance company to cover it will increase.

• If an HTC isn’t in-network, ask the insurance company to make an exception. When you call the number on the back of your insurance card, be prepared to tell them why you need this service. You’ll probably have to ask the HTC or provider to write a letter to the insurance company. If the insurance company still says no, you can file an appeal.

• If your insurance company doesn’t agree with the treatment plan that you and your healthcare provider have agreed on, you may need a letter of medical necessity. For example, if your treatment plan includes a prescription for a different factor replacement therapy than you currently use, a prior authorization may be required. If the insurance company still doesn’t approve it, you can appeal that decision.

• You’ll need to follow the processes for complaints and appeals that your insurance company requires, so keep good records of phone calls and correspondence (emails, letters, forms).

• You can get the details on the company’s process by calling the number on the back of your insurance card or going to the insurer’s website.

Bottom line: If you and your healthcare team think that you’re not getting medically necessary treatment approved, you’ve got to speak up!

Starring… Rasputin!

Doug and I went to see the movie Free Guy, starring the ever-hilarious Ryan Reynolds, a thoroughly delightful movie that seems like a cross between The Truman Show, Inception and Tron. We loved it. But it was the previews that caught my attention. The King’s Man is the upcoming prequel to the Kingsmen series. It’s set during World War I, and Rasputin will make an appearance, doing flying sidekicks and all sorts of things you don’t find in history books. As this week is the anniversary of the murder of Tsar Nicholas II and his entire family in a basement Siberia, it got me thinking about Rasputin portrayed in film. He’s such a character, you almost could not make him up. But he was real and he had a huge role to play in the life of Alexei, the prince who had hemophilia, and the overthrow of the monarchy. Pretty sure he had nothing to do with the King’s Man.

Where else has Rasputin appeared? I found the following on the internet. Within nine months of Rasputin’s murder in 1917, there were two low budget silent films about Rasputin. Producer-director Herbert Brenon released The Fall of the Romanoffs, and producer William A. Brady released Rasputin, the Black Monk.

There was Rasputin, a 1929 silent film, produced by Momento Film Company and directed by Nikolai Larin. Rasputin, The Holy Devil is a 1930 German film produced and directed by Martin Berger. Rasputin, Dämon der Frauen was a 1932 German film;  and Rasputin and the Empress, was a 1932 MGM production, with Lionel Barrymore playing Rasputin!

There was La Tragédie impériale, a 1939 film based on the book by Alfred Neumann; Raspoutine, a 1953 French film directed by Georges Combret; never released in the United States or England. The Night They Killed Rasputin, a 1960 film;  Rasputin the Mad Monk, a 1966 Hammer film. Hammer was known for the horror genre so it seems right that Rasputin was played by Christopher Lee!

J’ai tué Raspoutine (I Killed Rasputin) is a 1967 film featuring an interview with the real Prince Felix Yussupov, who participated in his murder.

My favorite is the spectacular Nicholas and Alexandra, a 1971 epic British film based on the book by Robert and Suzanne Massie, who have a son with hemophilia. Rasputin was expertly played by Tom Baker.

Rasputin: Dark Servant of Destiny is a 1996 HBO TV film, in which Rasputin was played by one of my favorite actors Alan Rickman, who won a Golden Globe for his portrayal.

And finally the upcoming The King’s Man, a 2021 Matthew Vaughn film.  Welsh actor Rhys Ifans will play Rasputin, who will pull a lot of martial art moves apparently!

And surprise! Rasputin, an upcoming film to star Leonardo DiCaprio as Rasputin! Maybe this will be his second Oscar?

HemaBlog Archives
Categories